GWPH Stock Gains 3%: Epidiolex Green Lit by European Commission

GWPH stock

GWPH stock is witnessing solid gains in early session on Monday after GW Pharmaceuticals (NASDAQ:GWPH) announced that the European regulators approved the company’s CBD oil in two seizure disorders.

Impressive Development

The cannabis industry has been reeling from a supply slowdown over the past few months, and many pot stocks gave up their gains. However, today, the industry received a huge boost from the European Union. In a landmark development, the relevant regulatory authority in the European Union has approved the cannabis-based medicine called Epidiolex, manufactured by GW Pharmaceuticals, as a prescription.

This is ...

Read The Full Article On PotStockNews.com

Get the latest marijuana stock news, cannabis on stock news on PotStockNews

All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.